nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—CYP2D6—Gefitinib—lung cancer	0.0918	0.32	CbGbCtD
Nebivolol—CYP2D6—Vinorelbine—lung cancer	0.0707	0.246	CbGbCtD
Nebivolol—CYP2D6—Erlotinib—lung cancer	0.0543	0.189	CbGbCtD
Nebivolol—CYP2D6—Vinblastine—lung cancer	0.0436	0.152	CbGbCtD
Nebivolol—CYP2D6—Doxorubicin—lung cancer	0.0268	0.0933	CbGbCtD
Nebivolol—Paraesthesia—Vinorelbine—lung cancer	0.00124	0.00198	CcSEcCtD
Nebivolol—Cardiac disorder—Etoposide—lung cancer	0.00123	0.00197	CcSEcCtD
Nebivolol—Dyspnoea—Vinorelbine—lung cancer	0.00123	0.00196	CcSEcCtD
Nebivolol—Loss of consciousness—Irinotecan—lung cancer	0.00122	0.00196	CcSEcCtD
Nebivolol—Hypersensitivity—Vinblastine—lung cancer	0.00122	0.00195	CcSEcCtD
Nebivolol—Acute coronary syndrome—Docetaxel—lung cancer	0.00121	0.00194	CcSEcCtD
Nebivolol—Cardiac disorder—Paclitaxel—lung cancer	0.00121	0.00193	CcSEcCtD
Nebivolol—Myocardial infarction—Docetaxel—lung cancer	0.00121	0.00193	CcSEcCtD
Nebivolol—Asthenia—Vinblastine—lung cancer	0.00119	0.0019	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Vinorelbine—lung cancer	0.00119	0.0019	CcSEcCtD
Nebivolol—Fatigue—Vinorelbine—lung cancer	0.00119	0.0019	CcSEcCtD
Nebivolol—Hypersensitivity—Topotecan—lung cancer	0.00119	0.0019	CcSEcCtD
Nebivolol—Asthenia—Topotecan—lung cancer	0.00115	0.00185	CcSEcCtD
Nebivolol—Chest pain—Gemcitabine—lung cancer	0.00115	0.00185	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.00115	0.00183	CcSEcCtD
Nebivolol—Asthenia—Erlotinib—lung cancer	0.00114	0.00183	CcSEcCtD
Nebivolol—Mental disorder—Paclitaxel—lung cancer	0.00114	0.00183	CcSEcCtD
Nebivolol—Pruritus—Topotecan—lung cancer	0.00114	0.00182	CcSEcCtD
Nebivolol—Malnutrition—Paclitaxel—lung cancer	0.00113	0.00181	CcSEcCtD
Nebivolol—Diarrhoea—Vinblastine—lung cancer	0.00113	0.00181	CcSEcCtD
Nebivolol—Pruritus—Erlotinib—lung cancer	0.00113	0.0018	CcSEcCtD
Nebivolol—Gastrointestinal pain—Vinorelbine—lung cancer	0.00113	0.0018	CcSEcCtD
Nebivolol—Shock—Irinotecan—lung cancer	0.00112	0.00179	CcSEcCtD
Nebivolol—Nervous system disorder—Irinotecan—lung cancer	0.00111	0.00178	CcSEcCtD
Nebivolol—Thrombocytopenia—Irinotecan—lung cancer	0.00111	0.00178	CcSEcCtD
Nebivolol—Diarrhoea—Topotecan—lung cancer	0.0011	0.00176	CcSEcCtD
Nebivolol—Dizziness—Vinblastine—lung cancer	0.0011	0.00175	CcSEcCtD
Nebivolol—Urticaria—Vinorelbine—lung cancer	0.00109	0.00175	CcSEcCtD
Nebivolol—Diarrhoea—Erlotinib—lung cancer	0.00109	0.00174	CcSEcCtD
Nebivolol—Abdominal pain—Vinorelbine—lung cancer	0.00109	0.00174	CcSEcCtD
Nebivolol—Oedema peripheral—Docetaxel—lung cancer	0.00109	0.00174	CcSEcCtD
Nebivolol—Nervous system disorder—Gemcitabine—lung cancer	0.00108	0.00173	CcSEcCtD
Nebivolol—Thrombocytopenia—Gemcitabine—lung cancer	0.00108	0.00173	CcSEcCtD
Nebivolol—Renal failure acute—Doxorubicin—lung cancer	0.00108	0.00173	CcSEcCtD
Nebivolol—Skin disorder—Gemcitabine—lung cancer	0.00107	0.00172	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.00107	0.00171	CcSEcCtD
Nebivolol—Dizziness—Topotecan—lung cancer	0.00106	0.0017	CcSEcCtD
Nebivolol—Vomiting—Vinblastine—lung cancer	0.00105	0.00168	CcSEcCtD
Nebivolol—Dizziness—Erlotinib—lung cancer	0.00105	0.00168	CcSEcCtD
Nebivolol—Vertigo—Etoposide—lung cancer	0.00104	0.00166	CcSEcCtD
Nebivolol—Headache—Vinblastine—lung cancer	0.00104	0.00166	CcSEcCtD
Nebivolol—Angioedema—Paclitaxel—lung cancer	0.00104	0.00166	CcSEcCtD
Nebivolol—Insomnia—Irinotecan—lung cancer	0.00103	0.00164	CcSEcCtD
Nebivolol—Cardiac disorder—Docetaxel—lung cancer	0.00103	0.00164	CcSEcCtD
Nebivolol—Vomiting—Topotecan—lung cancer	0.00102	0.00164	CcSEcCtD
Nebivolol—Paraesthesia—Irinotecan—lung cancer	0.00102	0.00163	CcSEcCtD
Nebivolol—Vertigo—Paclitaxel—lung cancer	0.00102	0.00163	CcSEcCtD
Nebivolol—Syncope—Paclitaxel—lung cancer	0.00102	0.00163	CcSEcCtD
Nebivolol—Loss of consciousness—Etoposide—lung cancer	0.00102	0.00163	CcSEcCtD
Nebivolol—Rash—Topotecan—lung cancer	0.00101	0.00162	CcSEcCtD
Nebivolol—Hypersensitivity—Vinorelbine—lung cancer	0.00101	0.00162	CcSEcCtD
Nebivolol—Dermatitis—Topotecan—lung cancer	0.00101	0.00162	CcSEcCtD
Nebivolol—Vomiting—Erlotinib—lung cancer	0.00101	0.00162	CcSEcCtD
Nebivolol—Dyspnoea—Irinotecan—lung cancer	0.00101	0.00162	CcSEcCtD
Nebivolol—Nervous system disorder—Cisplatin—lung cancer	0.00101	0.00162	CcSEcCtD
Nebivolol—Somnolence—Irinotecan—lung cancer	0.00101	0.00161	CcSEcCtD
Nebivolol—Thrombocytopenia—Cisplatin—lung cancer	0.00101	0.00161	CcSEcCtD
Nebivolol—Headache—Topotecan—lung cancer	0.00101	0.00161	CcSEcCtD
Nebivolol—Rash—Erlotinib—lung cancer	0.001	0.00161	CcSEcCtD
Nebivolol—Dermatitis—Erlotinib—lung cancer	0.001	0.0016	CcSEcCtD
Nebivolol—Skin disorder—Cisplatin—lung cancer	0.001	0.0016	CcSEcCtD
Nebivolol—Insomnia—Gemcitabine—lung cancer	0.001	0.0016	CcSEcCtD
Nebivolol—Headache—Erlotinib—lung cancer	0.000997	0.0016	CcSEcCtD
Nebivolol—Loss of consciousness—Paclitaxel—lung cancer	0.000997	0.0016	CcSEcCtD
Nebivolol—Paraesthesia—Gemcitabine—lung cancer	0.000993	0.00159	CcSEcCtD
Nebivolol—Asthenia—Vinorelbine—lung cancer	0.000988	0.00158	CcSEcCtD
Nebivolol—Dyspnoea—Gemcitabine—lung cancer	0.000986	0.00158	CcSEcCtD
Nebivolol—Chest pain—Etoposide—lung cancer	0.000985	0.00158	CcSEcCtD
Nebivolol—Nausea—Vinblastine—lung cancer	0.000984	0.00157	CcSEcCtD
Nebivolol—Somnolence—Gemcitabine—lung cancer	0.000983	0.00157	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Irinotecan—lung cancer	0.00098	0.00157	CcSEcCtD
Nebivolol—Fatigue—Irinotecan—lung cancer	0.000979	0.00157	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000978	0.00157	CcSEcCtD
Nebivolol—Pruritus—Vinorelbine—lung cancer	0.000974	0.00156	CcSEcCtD
Nebivolol—Mental disorder—Docetaxel—lung cancer	0.000968	0.00155	CcSEcCtD
Nebivolol—Chest pain—Paclitaxel—lung cancer	0.000966	0.00155	CcSEcCtD
Nebivolol—Malnutrition—Docetaxel—lung cancer	0.000962	0.00154	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000959	0.00153	CcSEcCtD
Nebivolol—Nausea—Topotecan—lung cancer	0.000956	0.00153	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000955	0.00153	CcSEcCtD
Nebivolol—Fatigue—Gemcitabine—lung cancer	0.000953	0.00153	CcSEcCtD
Nebivolol—Nausea—Erlotinib—lung cancer	0.000946	0.00151	CcSEcCtD
Nebivolol—Diarrhoea—Vinorelbine—lung cancer	0.000942	0.00151	CcSEcCtD
Nebivolol—Gastrointestinal pain—Irinotecan—lung cancer	0.000928	0.00149	CcSEcCtD
Nebivolol—Paraesthesia—Cisplatin—lung cancer	0.000926	0.00148	CcSEcCtD
Nebivolol—Thrombocytopenia—Etoposide—lung cancer	0.000925	0.00148	CcSEcCtD
Nebivolol—Dyspnoea—Cisplatin—lung cancer	0.000919	0.00147	CcSEcCtD
Nebivolol—Skin disorder—Etoposide—lung cancer	0.000917	0.00147	CcSEcCtD
Nebivolol—Erectile dysfunction—Methotrexate—lung cancer	0.000916	0.00147	CcSEcCtD
Nebivolol—Shock—Paclitaxel—lung cancer	0.000911	0.00146	CcSEcCtD
Nebivolol—Dizziness—Vinorelbine—lung cancer	0.00091	0.00146	CcSEcCtD
Nebivolol—Nervous system disorder—Paclitaxel—lung cancer	0.000908	0.00145	CcSEcCtD
Nebivolol—Thrombocytopenia—Paclitaxel—lung cancer	0.000906	0.00145	CcSEcCtD
Nebivolol—Skin disorder—Paclitaxel—lung cancer	0.000899	0.00144	CcSEcCtD
Nebivolol—Abdominal pain—Irinotecan—lung cancer	0.000897	0.00144	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000897	0.00144	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Cisplatin—lung cancer	0.00089	0.00142	CcSEcCtD
Nebivolol—Vomiting—Vinorelbine—lung cancer	0.000875	0.0014	CcSEcCtD
Nebivolol—Rash—Vinorelbine—lung cancer	0.000868	0.00139	CcSEcCtD
Nebivolol—Dermatitis—Vinorelbine—lung cancer	0.000867	0.00139	CcSEcCtD
Nebivolol—Headache—Vinorelbine—lung cancer	0.000862	0.00138	CcSEcCtD
Nebivolol—Syncope—Docetaxel—lung cancer	0.000862	0.00138	CcSEcCtD
Nebivolol—Paraesthesia—Etoposide—lung cancer	0.000848	0.00136	CcSEcCtD
Nebivolol—Loss of consciousness—Docetaxel—lung cancer	0.000845	0.00135	CcSEcCtD
Nebivolol—Dyspnoea—Etoposide—lung cancer	0.000842	0.00135	CcSEcCtD
Nebivolol—Somnolence—Etoposide—lung cancer	0.000839	0.00134	CcSEcCtD
Nebivolol—Insomnia—Paclitaxel—lung cancer	0.000837	0.00134	CcSEcCtD
Nebivolol—Hypersensitivity—Irinotecan—lung cancer	0.000836	0.00134	CcSEcCtD
Nebivolol—Paraesthesia—Paclitaxel—lung cancer	0.000831	0.00133	CcSEcCtD
Nebivolol—Dyspnoea—Paclitaxel—lung cancer	0.000825	0.00132	CcSEcCtD
Nebivolol—Somnolence—Paclitaxel—lung cancer	0.000823	0.00132	CcSEcCtD
Nebivolol—Chest pain—Docetaxel—lung cancer	0.000819	0.00131	CcSEcCtD
Nebivolol—Nausea—Vinorelbine—lung cancer	0.000818	0.00131	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Etoposide—lung cancer	0.000815	0.0013	CcSEcCtD
Nebivolol—Asthenia—Irinotecan—lung cancer	0.000814	0.0013	CcSEcCtD
Nebivolol—Fatigue—Etoposide—lung cancer	0.000814	0.0013	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000813	0.0013	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000799	0.00128	CcSEcCtD
Nebivolol—Fatigue—Paclitaxel—lung cancer	0.000798	0.00128	CcSEcCtD
Nebivolol—Asthenia—Gemcitabine—lung cancer	0.000793	0.00127	CcSEcCtD
Nebivolol—Pruritus—Gemcitabine—lung cancer	0.000782	0.00125	CcSEcCtD
Nebivolol—Diarrhoea—Irinotecan—lung cancer	0.000777	0.00124	CcSEcCtD
Nebivolol—Gastrointestinal pain—Etoposide—lung cancer	0.000772	0.00124	CcSEcCtD
Nebivolol—Shock—Docetaxel—lung cancer	0.000772	0.00124	CcSEcCtD
Nebivolol—Nervous system disorder—Docetaxel—lung cancer	0.00077	0.00123	CcSEcCtD
Nebivolol—Thrombocytopenia—Docetaxel—lung cancer	0.000768	0.00123	CcSEcCtD
Nebivolol—Skin disorder—Docetaxel—lung cancer	0.000762	0.00122	CcSEcCtD
Nebivolol—Hypersensitivity—Cisplatin—lung cancer	0.000759	0.00121	CcSEcCtD
Nebivolol—Gastrointestinal pain—Paclitaxel—lung cancer	0.000757	0.00121	CcSEcCtD
Nebivolol—Diarrhoea—Gemcitabine—lung cancer	0.000757	0.00121	CcSEcCtD
Nebivolol—Dizziness—Irinotecan—lung cancer	0.000751	0.0012	CcSEcCtD
Nebivolol—Urticaria—Etoposide—lung cancer	0.00075	0.0012	CcSEcCtD
Nebivolol—Abdominal pain—Etoposide—lung cancer	0.000746	0.00119	CcSEcCtD
Nebivolol—Asthenia—Cisplatin—lung cancer	0.00074	0.00118	CcSEcCtD
Nebivolol—Cardiac disorder—Methotrexate—lung cancer	0.000739	0.00118	CcSEcCtD
Nebivolol—Urticaria—Paclitaxel—lung cancer	0.000736	0.00118	CcSEcCtD
Nebivolol—Abdominal pain—Paclitaxel—lung cancer	0.000732	0.00117	CcSEcCtD
Nebivolol—Vomiting—Irinotecan—lung cancer	0.000722	0.00115	CcSEcCtD
Nebivolol—Rash—Irinotecan—lung cancer	0.000716	0.00115	CcSEcCtD
Nebivolol—Dermatitis—Irinotecan—lung cancer	0.000715	0.00114	CcSEcCtD
Nebivolol—Headache—Irinotecan—lung cancer	0.000711	0.00114	CcSEcCtD
Nebivolol—Insomnia—Docetaxel—lung cancer	0.00071	0.00114	CcSEcCtD
Nebivolol—Diarrhoea—Cisplatin—lung cancer	0.000705	0.00113	CcSEcCtD
Nebivolol—Paraesthesia—Docetaxel—lung cancer	0.000705	0.00113	CcSEcCtD
Nebivolol—Vomiting—Gemcitabine—lung cancer	0.000703	0.00112	CcSEcCtD
Nebivolol—Bradycardia—Doxorubicin—lung cancer	0.000702	0.00112	CcSEcCtD
Nebivolol—Dyspnoea—Docetaxel—lung cancer	0.0007	0.00112	CcSEcCtD
Nebivolol—Somnolence—Docetaxel—lung cancer	0.000698	0.00112	CcSEcCtD
Nebivolol—Mental disorder—Methotrexate—lung cancer	0.000697	0.00112	CcSEcCtD
Nebivolol—Rash—Gemcitabine—lung cancer	0.000697	0.00112	CcSEcCtD
Nebivolol—Dermatitis—Gemcitabine—lung cancer	0.000697	0.00111	CcSEcCtD
Nebivolol—Hypersensitivity—Etoposide—lung cancer	0.000696	0.00111	CcSEcCtD
Nebivolol—Malnutrition—Methotrexate—lung cancer	0.000693	0.00111	CcSEcCtD
Nebivolol—Headache—Gemcitabine—lung cancer	0.000693	0.00111	CcSEcCtD
Nebivolol—Hypersensitivity—Paclitaxel—lung cancer	0.000682	0.00109	CcSEcCtD
Nebivolol—Oedema peripheral—Doxorubicin—lung cancer	0.000679	0.00109	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Docetaxel—lung cancer	0.000677	0.00108	CcSEcCtD
Nebivolol—Asthenia—Etoposide—lung cancer	0.000677	0.00108	CcSEcCtD
Nebivolol—Fatigue—Docetaxel—lung cancer	0.000677	0.00108	CcSEcCtD
Nebivolol—Nausea—Irinotecan—lung cancer	0.000674	0.00108	CcSEcCtD
Nebivolol—Pruritus—Etoposide—lung cancer	0.000668	0.00107	CcSEcCtD
Nebivolol—Asthenia—Paclitaxel—lung cancer	0.000664	0.00106	CcSEcCtD
Nebivolol—Nausea—Gemcitabine—lung cancer	0.000657	0.00105	CcSEcCtD
Nebivolol—Vomiting—Cisplatin—lung cancer	0.000655	0.00105	CcSEcCtD
Nebivolol—Pruritus—Paclitaxel—lung cancer	0.000655	0.00105	CcSEcCtD
Nebivolol—Rash—Cisplatin—lung cancer	0.00065	0.00104	CcSEcCtD
Nebivolol—Dermatitis—Cisplatin—lung cancer	0.000649	0.00104	CcSEcCtD
Nebivolol—Diarrhoea—Etoposide—lung cancer	0.000646	0.00103	CcSEcCtD
Nebivolol—Gastrointestinal pain—Docetaxel—lung cancer	0.000642	0.00103	CcSEcCtD
Nebivolol—Cardiac disorder—Doxorubicin—lung cancer	0.00064	0.00102	CcSEcCtD
Nebivolol—Diarrhoea—Paclitaxel—lung cancer	0.000633	0.00101	CcSEcCtD
Nebivolol—Dizziness—Etoposide—lung cancer	0.000624	0.000999	CcSEcCtD
Nebivolol—Vertigo—Methotrexate—lung cancer	0.000623	0.000996	CcSEcCtD
Nebivolol—Abdominal pain—Docetaxel—lung cancer	0.00062	0.000992	CcSEcCtD
Nebivolol—Dizziness—Paclitaxel—lung cancer	0.000612	0.000979	CcSEcCtD
Nebivolol—Nausea—Cisplatin—lung cancer	0.000612	0.000979	CcSEcCtD
Nebivolol—Mental disorder—Doxorubicin—lung cancer	0.000604	0.000966	CcSEcCtD
Nebivolol—Vomiting—Etoposide—lung cancer	0.0006	0.000961	CcSEcCtD
Nebivolol—Malnutrition—Doxorubicin—lung cancer	0.0006	0.00096	CcSEcCtD
Nebivolol—Rash—Etoposide—lung cancer	0.000595	0.000953	CcSEcCtD
Nebivolol—Dermatitis—Etoposide—lung cancer	0.000595	0.000952	CcSEcCtD
Nebivolol—Headache—Etoposide—lung cancer	0.000592	0.000946	CcSEcCtD
Nebivolol—Chest pain—Methotrexate—lung cancer	0.00059	0.000944	CcSEcCtD
Nebivolol—Vomiting—Paclitaxel—lung cancer	0.000589	0.000942	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000586	0.000937	CcSEcCtD
Nebivolol—Rash—Paclitaxel—lung cancer	0.000584	0.000934	CcSEcCtD
Nebivolol—Dermatitis—Paclitaxel—lung cancer	0.000583	0.000933	CcSEcCtD
Nebivolol—Headache—Paclitaxel—lung cancer	0.00058	0.000928	CcSEcCtD
Nebivolol—Hypersensitivity—Docetaxel—lung cancer	0.000578	0.000925	CcSEcCtD
Nebivolol—Asthenia—Docetaxel—lung cancer	0.000563	0.000901	CcSEcCtD
Nebivolol—Nausea—Etoposide—lung cancer	0.000561	0.000897	CcSEcCtD
Nebivolol—Pruritus—Docetaxel—lung cancer	0.000555	0.000888	CcSEcCtD
Nebivolol—Nervous system disorder—Methotrexate—lung cancer	0.000555	0.000887	CcSEcCtD
Nebivolol—Thrombocytopenia—Methotrexate—lung cancer	0.000554	0.000886	CcSEcCtD
Nebivolol—Nausea—Paclitaxel—lung cancer	0.00055	0.00088	CcSEcCtD
Nebivolol—Skin disorder—Methotrexate—lung cancer	0.000549	0.000879	CcSEcCtD
Nebivolol—Vertigo—Doxorubicin—lung cancer	0.000539	0.000863	CcSEcCtD
Nebivolol—Syncope—Doxorubicin—lung cancer	0.000538	0.000861	CcSEcCtD
Nebivolol—Diarrhoea—Docetaxel—lung cancer	0.000537	0.000859	CcSEcCtD
Nebivolol—Loss of consciousness—Doxorubicin—lung cancer	0.000527	0.000844	CcSEcCtD
Nebivolol—Dizziness—Docetaxel—lung cancer	0.000519	0.00083	CcSEcCtD
Nebivolol—Insomnia—Methotrexate—lung cancer	0.000512	0.000818	CcSEcCtD
Nebivolol—Chest pain—Doxorubicin—lung cancer	0.000511	0.000817	CcSEcCtD
Nebivolol—Paraesthesia—Methotrexate—lung cancer	0.000508	0.000813	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000507	0.000812	CcSEcCtD
Nebivolol—Dyspnoea—Methotrexate—lung cancer	0.000504	0.000807	CcSEcCtD
Nebivolol—Somnolence—Methotrexate—lung cancer	0.000503	0.000804	CcSEcCtD
Nebivolol—Vomiting—Docetaxel—lung cancer	0.000499	0.000798	CcSEcCtD
Nebivolol—Rash—Docetaxel—lung cancer	0.000495	0.000792	CcSEcCtD
Nebivolol—Dermatitis—Docetaxel—lung cancer	0.000494	0.000791	CcSEcCtD
Nebivolol—Headache—Docetaxel—lung cancer	0.000492	0.000787	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Methotrexate—lung cancer	0.000488	0.000781	CcSEcCtD
Nebivolol—Fatigue—Methotrexate—lung cancer	0.000488	0.00078	CcSEcCtD
Nebivolol—Shock—Doxorubicin—lung cancer	0.000482	0.000771	CcSEcCtD
Nebivolol—Nervous system disorder—Doxorubicin—lung cancer	0.00048	0.000768	CcSEcCtD
Nebivolol—Thrombocytopenia—Doxorubicin—lung cancer	0.00048	0.000767	CcSEcCtD
Nebivolol—Skin disorder—Doxorubicin—lung cancer	0.000476	0.000761	CcSEcCtD
Nebivolol—Nausea—Docetaxel—lung cancer	0.000466	0.000746	CcSEcCtD
Nebivolol—Gastrointestinal pain—Methotrexate—lung cancer	0.000463	0.00074	CcSEcCtD
Nebivolol—Urticaria—Methotrexate—lung cancer	0.000449	0.000719	CcSEcCtD
Nebivolol—Abdominal pain—Methotrexate—lung cancer	0.000447	0.000715	CcSEcCtD
Nebivolol—Insomnia—Doxorubicin—lung cancer	0.000443	0.000709	CcSEcCtD
Nebivolol—Paraesthesia—Doxorubicin—lung cancer	0.00044	0.000704	CcSEcCtD
Nebivolol—Dyspnoea—Doxorubicin—lung cancer	0.000437	0.000699	CcSEcCtD
Nebivolol—Somnolence—Doxorubicin—lung cancer	0.000435	0.000697	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000423	0.000676	CcSEcCtD
Nebivolol—Fatigue—Doxorubicin—lung cancer	0.000422	0.000676	CcSEcCtD
Nebivolol—Hypersensitivity—Methotrexate—lung cancer	0.000417	0.000667	CcSEcCtD
Nebivolol—Asthenia—Methotrexate—lung cancer	0.000406	0.000649	CcSEcCtD
Nebivolol—Gastrointestinal pain—Doxorubicin—lung cancer	0.0004	0.000641	CcSEcCtD
Nebivolol—Pruritus—Methotrexate—lung cancer	0.0004	0.00064	CcSEcCtD
Nebivolol—Urticaria—Doxorubicin—lung cancer	0.000389	0.000622	CcSEcCtD
Nebivolol—Abdominal pain—Doxorubicin—lung cancer	0.000387	0.000619	CcSEcCtD
Nebivolol—Diarrhoea—Methotrexate—lung cancer	0.000387	0.000619	CcSEcCtD
Nebivolol—Dizziness—Methotrexate—lung cancer	0.000374	0.000598	CcSEcCtD
Nebivolol—Hypersensitivity—Doxorubicin—lung cancer	0.000361	0.000577	CcSEcCtD
Nebivolol—Vomiting—Methotrexate—lung cancer	0.00036	0.000575	CcSEcCtD
Nebivolol—Rash—Methotrexate—lung cancer	0.000357	0.000571	CcSEcCtD
Nebivolol—Dermatitis—Methotrexate—lung cancer	0.000356	0.00057	CcSEcCtD
Nebivolol—Headache—Methotrexate—lung cancer	0.000354	0.000567	CcSEcCtD
Nebivolol—Asthenia—Doxorubicin—lung cancer	0.000351	0.000562	CcSEcCtD
Nebivolol—Pruritus—Doxorubicin—lung cancer	0.000346	0.000554	CcSEcCtD
Nebivolol—Nausea—Methotrexate—lung cancer	0.000336	0.000537	CcSEcCtD
Nebivolol—Diarrhoea—Doxorubicin—lung cancer	0.000335	0.000536	CcSEcCtD
Nebivolol—Dizziness—Doxorubicin—lung cancer	0.000324	0.000518	CcSEcCtD
Nebivolol—Vomiting—Doxorubicin—lung cancer	0.000311	0.000498	CcSEcCtD
Nebivolol—Rash—Doxorubicin—lung cancer	0.000309	0.000494	CcSEcCtD
Nebivolol—Dermatitis—Doxorubicin—lung cancer	0.000309	0.000494	CcSEcCtD
Nebivolol—Headache—Doxorubicin—lung cancer	0.000307	0.000491	CcSEcCtD
Nebivolol—Nausea—Doxorubicin—lung cancer	0.000291	0.000465	CcSEcCtD
Nebivolol—ADRB2—Signaling by GPCR—PIK3CG—lung cancer	4.19e-05	0.000477	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PIK3CD—lung cancer	4.15e-05	0.000472	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PIK3CG—lung cancer	4.1e-05	0.000466	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GSTA1—lung cancer	4.09e-05	0.000465	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—POMC—lung cancer	4.08e-05	0.000464	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PIK3CD—lung cancer	4.06e-05	0.000461	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ABCC3—lung cancer	4.05e-05	0.00046	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—STK11—lung cancer	4.01e-05	0.000456	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—POMC—lung cancer	3.99e-05	0.000454	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—IL6R—lung cancer	3.98e-05	0.000452	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PIK3CD—lung cancer	3.97e-05	0.000451	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—STK11—lung cancer	3.92e-05	0.000446	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—AKR1C1—lung cancer	3.92e-05	0.000445	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—POMC—lung cancer	3.9e-05	0.000444	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—IL6R—lung cancer	3.89e-05	0.000443	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—FOXO3—lung cancer	3.87e-05	0.00044	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—STK11—lung cancer	3.84e-05	0.000436	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—IL6R—lung cancer	3.81e-05	0.000433	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—UGT1A1—lung cancer	3.8e-05	0.000432	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—MAP2K1—lung cancer	3.79e-05	0.000431	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—FOXO3—lung cancer	3.79e-05	0.00043	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PIK3CD—lung cancer	3.77e-05	0.000428	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—MAP2K1—lung cancer	3.71e-05	0.000422	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—FOXO3—lung cancer	3.7e-05	0.000421	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PIK3CD—lung cancer	3.69e-05	0.000419	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GNG11—lung cancer	3.67e-05	0.000417	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—MAP2K1—lung cancer	3.63e-05	0.000412	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AVP—lung cancer	3.63e-05	0.000412	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PIK3CB—lung cancer	3.62e-05	0.000411	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PIK3CD—lung cancer	3.6e-05	0.00041	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AVP—lung cancer	3.55e-05	0.000403	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PIK3CB—lung cancer	3.54e-05	0.000402	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALDOA—lung cancer	3.49e-05	0.000397	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IGF1R—lung cancer	3.49e-05	0.000397	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—CXCL8—lung cancer	3.48e-05	0.000395	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AVP—lung cancer	3.47e-05	0.000394	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PIK3CB—lung cancer	3.46e-05	0.000393	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HES1—lung cancer	3.43e-05	0.00039	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IGF1R—lung cancer	3.42e-05	0.000388	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—CXCL8—lung cancer	3.4e-05	0.000386	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—NCOA3—lung cancer	3.39e-05	0.000385	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—RAF1—lung cancer	3.36e-05	0.000382	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HES1—lung cancer	3.36e-05	0.000381	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IGF1R—lung cancer	3.34e-05	0.00038	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—CXCL8—lung cancer	3.32e-05	0.000378	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—IL2—lung cancer	3.32e-05	0.000378	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ABCG2—lung cancer	3.3e-05	0.000375	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ADCY1—lung cancer	3.3e-05	0.000375	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—RAF1—lung cancer	3.29e-05	0.000374	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PIK3CB—lung cancer	3.28e-05	0.000373	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HES1—lung cancer	3.28e-05	0.000373	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—IL2—lung cancer	3.25e-05	0.000369	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—HPGDS—lung cancer	3.23e-05	0.000368	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ENO2—lung cancer	3.23e-05	0.000368	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—RAF1—lung cancer	3.22e-05	0.000366	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PPP2R1B—lung cancer	3.21e-05	0.000365	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PIK3CB—lung cancer	3.21e-05	0.000365	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—IL2—lung cancer	3.18e-05	0.000361	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—CXCL8—lung cancer	3.16e-05	0.000359	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PIK3CB—lung cancer	3.14e-05	0.000357	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GSTT1—lung cancer	3.14e-05	0.000357	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ERBB3—lung cancer	3.14e-05	0.000356	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GCLC—lung cancer	3.1e-05	0.000352	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP2A6—lung cancer	3.1e-05	0.000352	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CXCL8—lung cancer	3.09e-05	0.000351	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ERBB3—lung cancer	3.07e-05	0.000349	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CXCL8—lung cancer	3.02e-05	0.000343	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—IL2—lung cancer	3.02e-05	0.000343	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TERT—lung cancer	3.01e-05	0.000342	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ERBB3—lung cancer	3e-05	0.000341	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—IL2—lung cancer	2.95e-05	0.000335	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TERT—lung cancer	2.94e-05	0.000334	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ENO1—lung cancer	2.94e-05	0.000334	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—FGFR1—lung cancer	2.92e-05	0.000332	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—IL2—lung cancer	2.89e-05	0.000328	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TERT—lung cancer	2.87e-05	0.000327	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HIF1A—lung cancer	2.87e-05	0.000327	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—FGFR1—lung cancer	2.85e-05	0.000324	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HIF1A—lung cancer	2.81e-05	0.00032	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—FGFR1—lung cancer	2.79e-05	0.000317	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APOA1—lung cancer	2.77e-05	0.000315	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HIF1A—lung cancer	2.75e-05	0.000312	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—KDR—lung cancer	2.75e-05	0.000312	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APOA1—lung cancer	2.71e-05	0.000308	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—KDR—lung cancer	2.69e-05	0.000306	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APOA1—lung cancer	2.65e-05	0.000302	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP2E1—lung cancer	2.64e-05	0.0003	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—KDR—lung cancer	2.63e-05	0.000299	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—NQO1—lung cancer	2.61e-05	0.000296	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APC—lung cancer	2.53e-05	0.000288	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—KIT—lung cancer	2.53e-05	0.000288	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3CG—lung cancer	2.53e-05	0.000288	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—NRAS—lung cancer	2.53e-05	0.000288	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—EGF—lung cancer	2.5e-05	0.000284	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3CG—lung cancer	2.48e-05	0.000282	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APC—lung cancer	2.48e-05	0.000282	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—KIT—lung cancer	2.48e-05	0.000282	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—NRAS—lung cancer	2.48e-05	0.000282	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—EGF—lung cancer	2.45e-05	0.000278	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—MAPK3—lung cancer	2.43e-05	0.000276	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3CG—lung cancer	2.42e-05	0.000275	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APC—lung cancer	2.42e-05	0.000275	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—KIT—lung cancer	2.42e-05	0.000275	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—NRAS—lung cancer	2.42e-05	0.000275	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—POMC—lung cancer	2.41e-05	0.000274	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—EGF—lung cancer	2.39e-05	0.000272	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—BRAF—lung cancer	2.38e-05	0.000271	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—MAPK3—lung cancer	2.37e-05	0.00027	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—POMC—lung cancer	2.36e-05	0.000268	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IL6R—lung cancer	2.35e-05	0.000267	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—STK11—lung cancer	2.35e-05	0.000267	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CREBBP—lung cancer	2.35e-05	0.000267	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—BRAF—lung cancer	2.33e-05	0.000265	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—MAPK3—lung cancer	2.32e-05	0.000264	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—EGFR—lung cancer	2.31e-05	0.000262	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—POMC—lung cancer	2.31e-05	0.000262	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IL6R—lung cancer	2.3e-05	0.000261	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CREBBP—lung cancer	2.3e-05	0.000261	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—BRAF—lung cancer	2.28e-05	0.000259	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—EGFR—lung cancer	2.26e-05	0.000257	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IL6R—lung cancer	2.25e-05	0.000256	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CREBBP—lung cancer	2.25e-05	0.000255	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MAP2K1—lung cancer	2.24e-05	0.000255	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3CD—lung cancer	2.23e-05	0.000253	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—EGFR—lung cancer	2.21e-05	0.000251	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PIK3CA—lung cancer	2.2e-05	0.000251	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MAP2K1—lung cancer	2.19e-05	0.000249	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—KRAS—lung cancer	2.18e-05	0.000248	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3CD—lung cancer	2.18e-05	0.000248	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GSTP1—lung cancer	2.17e-05	0.000247	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PIK3CA—lung cancer	2.16e-05	0.000245	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MAP2K1—lung cancer	2.14e-05	0.000244	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—KRAS—lung cancer	2.13e-05	0.000242	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3CD—lung cancer	2.13e-05	0.000242	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CAT—lung cancer	2.12e-05	0.00024	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PIK3CA—lung cancer	2.11e-05	0.00024	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—KRAS—lung cancer	2.08e-05	0.000237	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ABCB1—lung cancer	2.06e-05	0.000234	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—TYMS—lung cancer	2.02e-05	0.00023	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PIK3CA—lung cancer	2e-05	0.000228	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GSTM1—lung cancer	2e-05	0.000227	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MDM2—lung cancer	1.99e-05	0.000227	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—RAF1—lung cancer	1.99e-05	0.000226	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ERBB2—lung cancer	1.97e-05	0.000223	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PIK3CA—lung cancer	1.96e-05	0.000223	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MDM2—lung cancer	1.95e-05	0.000222	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—RAF1—lung cancer	1.94e-05	0.000221	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MTOR—lung cancer	1.94e-05	0.000221	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3CB—lung cancer	1.94e-05	0.000221	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ERBB2—lung cancer	1.92e-05	0.000219	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PIK3CA—lung cancer	1.92e-05	0.000218	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MDM2—lung cancer	1.91e-05	0.000217	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—RAF1—lung cancer	1.9e-05	0.000216	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3CB—lung cancer	1.9e-05	0.000216	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MTOR—lung cancer	1.9e-05	0.000216	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP1A1—lung cancer	1.89e-05	0.000215	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ERBB2—lung cancer	1.88e-05	0.000214	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ERCC2—lung cancer	1.88e-05	0.000214	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CXCL8—lung cancer	1.86e-05	0.000212	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MTOR—lung cancer	1.86e-05	0.000211	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3CB—lung cancer	1.86e-05	0.000211	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—HRAS—lung cancer	1.85e-05	0.000211	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CXCL8—lung cancer	1.82e-05	0.000207	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—HRAS—lung cancer	1.81e-05	0.000206	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—AKT1—lung cancer	1.8e-05	0.000205	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CASP3—lung cancer	1.78e-05	0.000203	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CXCL8—lung cancer	1.78e-05	0.000203	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IL2—lung cancer	1.78e-05	0.000203	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—IL6—lung cancer	1.77e-05	0.000202	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—HRAS—lung cancer	1.77e-05	0.000201	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—AKT1—lung cancer	1.76e-05	0.0002	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CASP3—lung cancer	1.75e-05	0.000198	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IL2—lung cancer	1.74e-05	0.000198	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCND1—lung cancer	1.74e-05	0.000197	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—IL6—lung cancer	1.73e-05	0.000197	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—JUN—lung cancer	1.73e-05	0.000197	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—AKT1—lung cancer	1.72e-05	0.000196	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CASP3—lung cancer	1.71e-05	0.000194	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IL2—lung cancer	1.7e-05	0.000194	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCND1—lung cancer	1.7e-05	0.000193	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—IL6—lung cancer	1.7e-05	0.000193	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—JUN—lung cancer	1.7e-05	0.000193	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MMP9—lung cancer	1.69e-05	0.000192	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CDKN1A—lung cancer	1.68e-05	0.000191	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PTEN—lung cancer	1.68e-05	0.000191	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCND1—lung cancer	1.66e-05	0.000189	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—JUN—lung cancer	1.66e-05	0.000188	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MMP9—lung cancer	1.65e-05	0.000188	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CDKN1A—lung cancer	1.64e-05	0.000187	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PTEN—lung cancer	1.64e-05	0.000186	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—AKT1—lung cancer	1.64e-05	0.000186	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOA1—lung cancer	1.62e-05	0.000185	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MMP9—lung cancer	1.61e-05	0.000183	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CDKN1A—lung cancer	1.61e-05	0.000183	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PTEN—lung cancer	1.6e-05	0.000182	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—AKT1—lung cancer	1.6e-05	0.000182	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—EP300—lung cancer	1.6e-05	0.000182	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—AKT1—lung cancer	1.56e-05	0.000178	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—EP300—lung cancer	1.56e-05	0.000178	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SRC—lung cancer	1.55e-05	0.000177	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—EP300—lung cancer	1.53e-05	0.000174	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SRC—lung cancer	1.52e-05	0.000173	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—VEGFA—lung cancer	1.51e-05	0.000172	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—STAT3—lung cancer	1.5e-05	0.00017	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NRAS—lung cancer	1.5e-05	0.00017	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SRC—lung cancer	1.49e-05	0.000169	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3CG—lung cancer	1.48e-05	0.000169	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—VEGFA—lung cancer	1.48e-05	0.000168	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—STAT3—lung cancer	1.47e-05	0.000167	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NRAS—lung cancer	1.46e-05	0.000166	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—VEGFA—lung cancer	1.45e-05	0.000165	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—STAT3—lung cancer	1.43e-05	0.000163	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MAPK3—lung cancer	1.43e-05	0.000163	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NRAS—lung cancer	1.43e-05	0.000163	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—POMC—lung cancer	1.41e-05	0.000161	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MAPK3—lung cancer	1.4e-05	0.000159	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MYC—lung cancer	1.39e-05	0.000158	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CREBBP—lung cancer	1.38e-05	0.000156	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MAPK3—lung cancer	1.37e-05	0.000156	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MYC—lung cancer	1.36e-05	0.000155	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—EGFR—lung cancer	1.36e-05	0.000155	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—EGFR—lung cancer	1.33e-05	0.000152	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MYC—lung cancer	1.33e-05	0.000151	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3CD—lung cancer	1.3e-05	0.000148	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—EGFR—lung cancer	1.3e-05	0.000148	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—KRAS—lung cancer	1.29e-05	0.000146	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALB—lung cancer	1.29e-05	0.000146	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—KRAS—lung cancer	1.26e-05	0.000143	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—KRAS—lung cancer	1.23e-05	0.00014	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3CA—lung cancer	1.18e-05	0.000134	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3CA—lung cancer	1.16e-05	0.000132	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TP53—lung cancer	1.14e-05	0.00013	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3CB—lung cancer	1.14e-05	0.000129	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3CA—lung cancer	1.13e-05	0.000129	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PTGS2—lung cancer	1.13e-05	0.000128	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TP53—lung cancer	1.12e-05	0.000127	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TP53—lung cancer	1.09e-05	0.000124	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HRAS—lung cancer	1.09e-05	0.000124	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HRAS—lung cancer	1.07e-05	0.000122	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IL6—lung cancer	1.05e-05	0.000119	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HRAS—lung cancer	1.05e-05	0.000119	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IL6—lung cancer	1.02e-05	0.000116	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IL6—lung cancer	1e-05	0.000114	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PTEN—lung cancer	9.82e-06	0.000112	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AKT1—lung cancer	9.66e-06	0.00011	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AKT1—lung cancer	9.45e-06	0.000107	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—EP300—lung cancer	9.37e-06	0.000106	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AKT1—lung cancer	9.24e-06	0.000105	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3CA—lung cancer	6.93e-06	7.88e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—AKT1—lung cancer	5.66e-06	6.43e-05	CbGpPWpGaD
